Evidence map›Paper›PMID 25280447›Full record

ArticleAIDS and behavior2014

The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study.

Jane M Simoni, David Huh, Yan Wang, Ira B Wilson, Nancy R Reynolds, Robert H Remien, Kathy Goggin, Robert Gross, Marc I Rosen, Neil Schneiderman and 5 more

Registry-linked trialAbstract readValidation Study
In one paragraph

Article in AIDS and behavior, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03302299 (URBAN ARCH), which is not on this map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03302299 phase4completednot on this mapstarted 2017, after this paper: background citation

URBAN ARCH (3/5) Uganda Cohort TB Preventive Therapy for HIV-infected Alcohol Users in Uganda: an Evaluation of Safety Tolerability and Adherence

TypeinterventionalSponsorUniversity of California, San FranciscoRan2017 to 2021Enrolled302ConditionsTuberculosis, HIV/AIDS, Alcohol AbuseArmsIsoniazid 300 Mg ORAL TABLET, Pyridoxine 25 Mg Oral Tablet
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Evaluation of a Remote Therapeutic Monitoring Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jane M SimoniDepartment of Psychology, University of Washington, Box 351525, Seattle, WA, 98195, USA, jsimoni@uw.edu.
David Huh
Yan Wang
Ira B Wilson
Nancy R Reynolds
Robert H Remien
Kathy Goggin
Robert Gross
Marc I Rosen
Neil Schneiderman
Julia Arnsten
Carol E Golin
Judith A Erlen
David R Bangsberg
Honghu Liu

Funding

WOMEN'S HEALTH AGENDAU01AI038858 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI BENSON, CONSTANCE ANN · 1996 to 2008
$157.5M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart · 1988 to 2026
$104.9M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials UnitUM1AI069419 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 2012 to 2026
$44.6M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
HIV-1, ETHNICITY, GENDER AND ACUTE STRESS REACTIVITYP01MH049548 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI KUMAR, MAHENDRA · 1993 to 2002
$8.5M
Cornell Clinical Trials UnitU01AI069419 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI GULICK, ROY M. · 2007 to 2011
$6.5M
Improving Adherence to Antiretroviral TherapyR01NR004749 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ERLEN, JUDITH A · 1998 to 2007
$3.6M
ART Adherence: Observed Therapy and Enhanced CounselingR01MH068197 · NIMH · UNIVERSITY OF MISSOURI KANSAS CITY · PI GOGGIN, KATHY J · 2004 to 2008
$3.6M
A TRAINING INTERVENTION TO ENHANCE ADHERENCE TO HAARTR01MH061695 · NIMH · RAND CORPORATION · PI KANOUSE, DAVID E · 2000 to 2004
$3.2M
Multi-Site Collaborative Study for Adherence Virologic and Clinical OutcomesR01MH078773 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIU, HONGHU · 2007 to 2011
$3.1M
CDC HHS CC02-SD-003CDC HHS CC99-SD003NIAID NIH HHS AI069419NIAID NIH HHS AI38858NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI050410NIAID NIH HHS P30AI050410NIAID NIH HHS P30AI27757NIAID NIH HHS R01AI41413NIAID NIH HHS U01 AI038858NIAID NIH HHS U01 AI069419NIAID NIH HHS UM1 AI069419NIDA NIH HHS K02 DA017277NIDA NIH HHS K02DA017277NIDA NIH HHS R01 DA011869NIDA NIH HHS R01 DA013826NIDA NIH HHS R01 DA015215NIDA NIH HHS R01 DA015679NIDA NIH HHS R01DA015679NIDA NIH HHS R01DA11869NIDA NIH HHS R01DA13826NIDA NIH HHS R01DA15215NIMH NIH HHS K08 MH001584NIMH NIH HHS K08 MH01584NIMH NIH HHS K23 MH001862NIMH NIH HHS K23MH01862NIMH NIH HHS K24 MH093243NIMH NIH HHS K24MH093243NIMH NIH HHS P01 MH049548NIMH NIH HHS P01MH49548NIMH NIH HHS P30 MH043520NIMH NIH HHS R01 MH054907NIMH NIH HHS R01 MH058986NIMH NIH HHS R01 MH061173NIMH NIH HHS R01 MH061695NIMH NIH HHS R01 MH068197NIMH NIH HHS R01MH068197NIMH NIH HHS R01 MH078773NIMH NIH HHS R01MH078773NIMH NIH HHS R01MH54907NIMH NIH HHS R01MH58986NIMH NIH HHS R01MH61173NIMH NIH HHS R01MH61695NINR NIH HHS 2R01NR04749NINR NIH HHS R01 NR004749NINR NIH HHS R01NR04749
6 · The paper itself

Abstract

In medication adherence-promotion trials, participants in the intervention arm are often cognizant of the researcher's aim to improve adherence; this may lead to their inflating reports of their own adherence compared to control arm participants. Using data from 1,247 HIV-positive participants across eight U.S. Studies in the Multi-site Adherence Collaboration on HIV (MACH14) collaboration, we evaluated the validity of self-reported adherence by examining whether its association with two more objective outcomes [1], electronically monitored adherence and [2] viral load, varied by study arm. After adjusting for potential confounders, there was no evidence of greater overestimation of self-reported adherence among intervention arm participants, supporting its potential as a trial outcome indicator.

Indexed as

Anti-HIV AgentsDrug MonitoringSelf ReportAdultAgedFemaleHealth PromotionHIV-1HIV InfectionsHumansMaleMiddle AgedProgram EvaluationReproducibility of ResultsUnited StatesViral LoadAnti-HIV Agents

Identifiers

PMID25280447
PMCPMC4495040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.